APC and cancer: This study is the first to report a broad lipidomic screen, using the LipidyzerTM platform, to identify specific lipid species as markers of CCx by comparing plasma from different CCx mouse models (NC26, C26, and LLC cell transplantation, Apc Min/+ mutation), and cachectic and weight stable cancer patients, which aimed to address whether the results found in animal models were translatable.